Mechanistic interrogation of mutation-independent disease modulators of RDEB identifies the small leucine-rich proteoglycan PRELP as a TGF-β antagonist and inhibitor of fibrosis
Titel:
Mechanistic interrogation of mutation-independent disease modulators of RDEB identifies the small leucine-rich proteoglycan PRELP as a TGF-β antagonist and inhibitor of fibrosis
Auteur:
Chacón-Solano, E. León, C. Carretero, M. García, M. Sánchez-Domínguez, R. Quero, F. Méndez-Jiménez, E. Bonafont, J. Ruiz-Mezcua, B. Escámez, M.J. Larcher, F. del Río, M.